Datopotamab deruxtecan (Datroway) is a novel Trop-2-targeted antibody-drug conjugate (ADC) co-developed by Daiichi Sankyo Co., Ltd. and AstraZeneca. It is used for the treatment of patients with HR-positive/HER2-negative metastatic breast cancer.

How to Purchase Datopotamab deruxtecan (Datroway)

Overseas Purchase

Patients may choose to consult and purchase Datopotamab deruxtecan at hospital pharmacies or authorized pharmacies in countries or regions where the drug has been launched.

Purchase via Medical Service Institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and can offer professional consultation and guidance.

Precautions for Purchasing Datopotamab deruxtecan (Datroway)

Verification of Usage Qualifications

Possess qualification for oncology specialist diagnosis and treatment.

Be equipped with emergency equipment and medications for managing infusion reactions.

Have professional pharmacists responsible for drug receipt, storage, and preparation.

Doctors have received special training on this medication.

Inspection of Packaging Integrity

The outer box clearly displays the "DATROWAY®" trademark.

Indicates "datopotamab deruxtecan-dlnk for injection" and the specification "100 mg/vial".

Bears the "Rx only" (prescription-only medicine) label.

Specifies the manufacturer "Daiichi Sankyo, Inc." and the marketing authorization number "U.S. License No. 2128".

Checking of Storage Conditions

Datroway must be strictly stored in its original packaging at 2-8℃ (36-46°F) and protected from light.

Methods for Identifying Authentic vs. Counterfeit Datopotamab deruxtecan (Datroway)

Anti-Counterfeiting Features of Packaging

The packaging box uses special materials and printing technology.

Includes a unique 2D barcode area.

Has a hidden "Glue Flap Code" on the inner side.

The instruction manual indicates the version information "Revised: 01/2025".

Is accompanied by an FDA-approved Medication Guide.

Identification of Drug Characteristics

Appears as a white to yellowish-white lyophilized powder.

Each vial contains 100mg of the active ingredient.

The reconstituted solution should be clear, colorless to pale yellow.

Contains no visible particles or precipitates.

The pH value of the reconstituted solution is 6.0.